| 000 | 01711 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250512004506.0 | ||
| 264 | 0 | _c19891023 | |
| 008 | 198910s 0 0 eng d | ||
| 022 | _a0361-7742 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPavone-Macaluso, M | |
| 245 | 0 | 0 |
_aEORTC protocol 30761: a randomized study of non-metastatic and metastatic prostatic cancer treated by cyproterone acetate versus diethylstilbestrol and medroxyprogesterone acetate. European Organization for Research on Treatment of Cancer Urological Group. _h[electronic resource] |
| 260 |
_bProgress in clinical and biological research _c1989 |
||
| 300 |
_a111-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
| 650 | 0 | 4 |
_aAndrogen Antagonists _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aCyproterone _xanalogs & derivatives |
| 650 | 0 | 4 | _aCyproterone Acetate |
| 650 | 0 | 4 |
_aDiethylstilbestrol _xtherapeutic use |
| 650 | 0 | 4 | _aEurope |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMedroxyprogesterone _xanalogs & derivatives |
| 650 | 0 | 4 | _aMedroxyprogesterone Acetate |
| 650 | 0 | 4 | _aMulticenter Studies as Topic |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aRandom Allocation |
| 700 | 1 | _aSchröder, F H | |
| 700 | 1 | _ade Voogt, H J | |
| 700 | 1 | _aViggiano, G | |
| 700 | 1 | _aBarasolo, E | |
| 700 | 1 | _aLardennois, B | |
| 700 | 1 | _ade Pauw, M | |
| 700 | 1 | _aSylvester, R | |
| 700 | 1 | _aSmith, P H | |
| 700 | 1 | _aSuciu, S | |
| 773 | 0 |
_tProgress in clinical and biological research _gvol. 303 _gp. 111-6 |
|
| 999 |
_c2534700 _d2534700 |
||